<DOC>
	<DOCNO>NCT02832271</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety green tea endometriosis .</brief_summary>
	<brief_title>Green Tea Endometriosis</brief_title>
	<detailed_description>Women endometrioma randomise either experimental group placebo comparator group 1:1 ratio . The subject give SUNPHENON EGCg placebo 3 month prior plan surgery .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Complaints pelvic pain , dysmenorrhoea and/or dyspareunia â‰¥ 6 month ; Verbal pain rating scale &gt; 4/10 visual analogue pain scale &gt; 4cm ; Ultrasound confirm endometrioma ; Planned surgery treatment within 46 month Age &lt; 20 year beyond &gt; 40 year behind active reproductive age ; BMI &lt; 18.5 kg/m2 underweight &gt; 25 kg/m2 overweight ; Chronic pelvic pain low back pain due medical condition , e.g . urological disorder orthopaedic disorder ; Secondary dysmenorrhoea due gynaecological condition endometriosis , e.g . pelvic inflammatory disease , genitourinary infection , gynaecological tumour , etc . ; Primary dysmenorrhoea without underlie disease identify ; Ultrasound suggest haemorrhagic ovarian cyst , ovarian dermoid cyst , cystic neoplasm , tuboovarian abscess ovarian pathology ; Chronic medical condition longterm medication ; Endometriosis active medication past 1 month ; History herbal medicine intake past 1 month</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>